Torimoto Keiichi, Okada Yosuke, Tanaka Yoshiya
First Department of Internal Medicine, School of Medicine, University of Occupational and Enviromental Health, Japan.
J UOEH. 2018;40(1):65-75. doi: 10.7888/juoeh.40.65.
Vascular endothelial function is important for maintaining the homeostasis of the living body. Especially, nitric oxide (NO) produced in vascular endothelial cells regulates blood vessel tone and has an antiatherosclerotic effect. Type 2 diabetes is a typical disease that causes impaired vascular endothelial function, resulting in various vascular complications and damage to organs. Cardiovascular disease associated with type 2 diabetes is a chronic inflammatory disease that starts with endothelial dysfunction (ED), and vascular ED is important as an initial change in arteriosclerotic lesions. Vascular ED in type 2 diabetes is thought to be caused by hyperglycemia, hyperinsulinemia associated with insulin resistance, and hypoglycemia, in which elevated oxidative stress accompanying postprandial hyperglycemia and blood glucose fluctuation are involved. Vascular ED is also caused by postprandial metabolic abnormalities, so correcting postprandial metabolic abnormalities is also important. Meanwhile, Glucagon-like peptide-1 (GLP-1) receptor agonist, thiazolidine, biguanide and Dipeptidyl peptidase-4 (DPP-4) inhibitor have an effect of protecting vascular endothelial function beyond glycemic control. In order to promote a healthy lifestyle for diabetes patients, it is important not only to lower HbA1c but also to avoid postprandial hyperglycemia, blood glucose fluctuation, and hypoglycemia. It is also important to conduct treatment with a view to suppressing vascular complications, such as the selection of antiarteriosclerosis medications.
血管内皮功能对于维持生物体的内环境稳定至关重要。特别是,血管内皮细胞产生的一氧化氮(NO)调节血管张力并具有抗动脉粥样硬化作用。2型糖尿病是一种典型的导致血管内皮功能受损的疾病,会引发各种血管并发症和器官损害。与2型糖尿病相关的心血管疾病是一种始于内皮功能障碍(ED)的慢性炎症性疾病,而血管ED作为动脉粥样硬化病变的初始变化很重要。2型糖尿病中的血管ED被认为是由高血糖、与胰岛素抵抗相关的高胰岛素血症以及低血糖引起的,其中餐后高血糖和血糖波动伴随的氧化应激升高也参与其中。血管ED也由餐后代谢异常引起,因此纠正餐后代谢异常也很重要。同时,胰高血糖素样肽-1(GLP-1)受体激动剂、噻唑烷二酮类、双胍类和二肽基肽酶-4(DPP-4)抑制剂除了控制血糖外,还具有保护血管内皮功能的作用。为了促进糖尿病患者的健康生活方式,不仅要降低糖化血红蛋白(HbA1c),还要避免餐后高血糖、血糖波动和低血糖。考虑到抑制血管并发症进行治疗也很重要,例如选择抗动脉硬化药物。